Macquarie Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $119M | Buy |
1,137,748
+161,488
| +17% | +$16.9M | 0.15% | 178 |
|
|
2025
Q1 | $114M | Buy |
976,260
+12,213
| +1% | +$1.42M | 0.14% | 200 |
|
|
2024
Q4 | $81.6M | Sell |
964,047
-31,240
| -3% | -$2.64M | 0.1% | 290 |
|
|
2024
Q3 | $89.4M | Sell |
995,287
-77,955
| -7% | -$7.01M | 0.1% | 283 |
|
|
2024
Q2 | $86.4M | Buy |
1,073,242
+372,832
| +53% | +$30M | 0.1% | 266 |
|
|
2024
Q1 | $55.9M | Buy |
700,410
+672,886
| +2,445% | +$53.7M | 0.06% | 396 |
|
|
2023
Q4 | $2.19M | Buy |
27,524
+6,009
| +28% | +$478K | ﹤0.01% | 1196 |
|
|
2023
Q3 | $1.5M | Sell |
21,515
-24,576
| -53% | -$1.72M | ﹤0.01% | 1240 |
|
|
2023
Q2 | $3.31M | Buy |
46,091
+26,187
| +132% | +$1.88M | ﹤0.01% | 1029 |
|
|
2023
Q1 | $1.23M | Buy |
19,904
+1,498
| +8% | +$92.4K | ﹤0.01% | 1311 |
|
|
2022
Q4 | $1.42M | Sell |
18,406
-9,301
| -34% | -$718K | ﹤0.01% | 1315 |
|
|
2022
Q3 | $1.24M | Sell |
27,707
-6,520
| -19% | -$292K | ﹤0.01% | 1368 |
|
|
2022
Q2 | $1.31M | Sell |
34,227
-5,047
| -13% | -$193K | ﹤0.01% | 1412 |
|
|
2022
Q1 | $1.63K | Buy |
39,274
+12,975
| +49% | +$537 | ﹤0.01% | 1427 |
|
|
2021
Q4 | $994K | Buy |
26,299
+54
| +0.2% | +$2.04K | ﹤0.01% | 1556 |
|
|
2021
Q3 | $865K | Buy |
26,245
+1,608
| +7% | +$53K | ﹤0.01% | 1615 |
|
|
2021
Q2 | $1.66M | Buy |
24,637
+2,946
| +14% | +$199K | ﹤0.01% | 1471 |
|
|
2021
Q1 | $1.23M | Buy |
21,691
+2,751
| +15% | +$156K | ﹤0.01% | 1344 |
|
|
2020
Q4 | $1.54M | Buy |
18,940
+17,772
| +1,522% | +$1.45M | ﹤0.01% | 1182 |
|
|
2020
Q3 | $83K | Hold |
1,168
| – | – | ﹤0.01% | 1830 |
|
|
2020
Q2 | $96K | Buy |
+1,168
| New | +$96K | ﹤0.01% | 1759 |
|